Composition and methods for treatment of hiv infection
CA 2319356 A1 · Owner: Childrens Hospital Los Angeles Research Institute · Inventors: Avramis, Vassilios I.; Cohen, Lewis
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Method of inhibiting or treating Human Immunodeficiency Virus (HIV) infection comprising administering to a patient in need thereof an effective amount of a pharmaceutically acceptable composition comprising a PEG-ASNase compound and optionally at least one compound selected from the group consisting of protease inhibitor compounds, ribonucleotide reductase inhibitor compounds and HIV reverse transcriptase inhibitor compounds.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 9, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 9, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 9, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.